• Acknowledgements

    ICI would like to recognize our partners, whose contributions ensure ICI's commitment to the highest standards of education excellence.

    Cordis Cardiac & Vascular Institute

    The Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Cordis is the world's leading developer and manufacturer of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.

    Society for Cardiovascular Angiography and Interventions

    Headquartered in Washington, DC, the Society for Cardiovascular Angiography and Interventions (SCAI) is a 4,000-member professional organization representing invasive and interventional cardiologists in 70 nations. SCAI’s mission is to promote excellence in invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI’s annual meeting has become the leading venue for education, discussion, and debate about the latest developments in this dynamic medical specialty.

    Cardiovascular Research Institute

    The Cardiovascular Research Foundation® (CRF) is a global leader in bringing together research, education, and patient care. Founded in 1991, CRF has played a key role in the development of nonsurgical and drug-based treatments of heart and vascular diseases and in the initital development of the IFI and ICI programs.


    The Interventional Fellows Institute was founded and first sponsored by the Weill Medical College of Cornell University.